Concepedia

Joel H. Tolentino

JH

Statistics

Publications

3

Citations

132

H-Index

3

Active since

2007

Affiliations

Molecular Oncology (United States)(Current)

Moffitt Cancer Center

Joel H. Tolentino is an author at Molecular Oncology (United States) specializing in tumor microenvironment, hematology, and immunology.

ORCID

Top concepts

Publications per year

2007–2012

3

Publications

3

Role of STAT3 in Transformation and Drug Resistance in CML

Rajesh R. Nair, Joel H. Tolentino, Lori Hazlehurst · Frontiers in Oncology · 2012 · 58 citations · Full text

, , +18

Inhibition of DNA replication fork progression and mutagenic potential of 1, N6-ethenoadenine and 8-oxoguanine in human cell extracts

Joel H. Tolentino, Thomas J. Burke, Sanghamitra Mukhopadhyay et al. · Nucleic Acids Research · 2007 · 39 citations · Full text

Potentiation of Nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML

Rajesh R. Nair, Joel H. Tolentino, Raul F. Argilagos et al. · Leukemia Research · 2011 · 35 citations

, , +12

1–3 of 3